TSFM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.584000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.863800E-01
Normal-vs-Stage2
9.630000E-01
Normal-vs-Stage3
2.812200E-01
Normal-vs-Stage4
7.655400E-01
Stage1-vs-Stage2
8.428600E-01
Stage1-vs-Stage3
1.506020E-01
Stage1-vs-Stage4
6.253800E-01
Stage2-vs-Stage3
1.790000E-01
Stage2-vs-Stage4
6.846800E-01
Stage3-vs-Stage4
5.630200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.083600E-01
Normal-vs-AfricanAmerican
8.666200E-01
Normal-vs-Asian
5.417800E-01
Caucasian-vs-AfricanAmerican
9.818200E-01
Caucasian-vs-Asian
1.994840E-01
AfricanAmerican-vs-Asian
3.388600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.253200E-01
Normal-vs-Female
9.851200E-01
Male-vs-Female
7.997800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.332800E-01
Normal-vs-Age(41-60Yrs)
6.141200E-01
Normal-vs-Age(61-80Yrs)
7.927400E-01
Normal-vs-Age(81-100Yrs)
8.285200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.444400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.512600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.851800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.295000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.695000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.983400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.277000E-01
Normal-vs-Daily Drinker
9.327600E-01
Normal-vs-Weekly Drinker
8.139400E-01
Normal-vs-Occasional Drinker
4.506800E-01
Normal-vs-Social Drinker
8.314400E-01
Non Drinker-vs-Daily Drinker
2.510600E-01
Non Drinker-vs-Weekly Drinker
1.342850E-01
Non Drinker-vs-Occasional Drinker
7.003200E-03
Non Drinker-vs-Social Drinker
1.351040E-01
Daily Drinker-vs-Weekly Drinker
5.259000E-01
Daily Drinker-vs-Occasional Drinker
9.978300E-02
Daily Drinker-vs-Social Drinker
5.616800E-01
Weekly Drinker-vs-Occasional Drinker
5.365200E-01
Weekly Drinker-vs-Social Drinker
9.415400E-01
Occasional Drinker-vs-Social Drinker
4.506000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.452400E-01
Normal-vs-Grade 2
7.757200E-01
Normal-vs-Grade 3
8.050600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.300380E-01
Grade 1-vs-Grade 3
4.243000E-01
Grade 1-vs-Grade 4
8.452400E-01
Grade 2-vs-Grade 3
3.628200E-01
Grade 2-vs-Grade 4
7.757200E-01
Grade 3-vs-Grade 4
8.050600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.639600E-01
Normal-vs-NonDiabetic
9.145800E-01
Diabetic-vs-NonDiabetic
4.064800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.957200E-01
Normal-vs-NoPancreatitis
9.642400E-01
Pancreatitis-vs-NoPancreatitis
4.500500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.450200E-01
Normal-vs-N1
9.653200E-01
N0-vs-N1
3.755200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.969000E-01
Normal-vs-TP53-NonMutant
7.288000E-01
TP53-Mutant-vs-TP53-NonMutant
7.334200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
